Your session is about to expire
← Back to Search
cRFA Guidance Techniques for Knee Osteoarthritis
Study Summary
This trial will compare the efficacy of using cooled radiofrequency ablation guided by fluoroscopy versus ultrasound in treating knee osteoarthritis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a radiofrequency ablation procedure on my knee.I have had knee replacement surgery.My knee pain hasn't improved with standard treatments for over 3 months.I have been diagnosed with knee osteoarthritis by the American College of Rheumatology standards.I am unable to give my own consent due to a condition like dementia.I do not have any uncontrolled medical or mental health issues.I do not speak English.I am younger than 35 years old.I do not have any infections where the needle or probe will be placed.I cannot walk by myself.I have experienced pain of at least a 4 out of 10 nearly every day last week.My knee arthritis is due to an autoimmune condition like rheumatoid or psoriatic arthritis.
- Group 1: Subjects with knee OA using fluoroscopy for cRFA intervention
- Group 2: Subjects with knee OA using ultrasound for cRFA intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What demographic is eligible for enrolling in this investigation?
"This medical study is seeking 90 participants, aged 35-99, suffering from knee osteoarthritis. To be considered eligible for the trial they must meet all of the following criteria: 1) diagnosis in accordance with American College of Rheumatology guidelines; 2) Kellgren-Lawrence score between two and four; 3) pain intensity reported as a minimum NPRS score of 4 on most days during the past week; 4) resistant to conventional treatments that may include medications (acetaminophen/NSAIDs/opioids), physical therapy or intra-articular injections (corticosteroids/hyaluronic acid"
Is geriatric participation encouraged for this research trial?
"According to the eligibility standards of this clinical trial, individuals must be between 35 and 99 years old."
In what maximum capacity are individuals participating in this research endeavor?
"This study necessitates the recruitment of 90 qualified patients. Potential applicants can come from UC Davis Health in Sacramento, California and UF and Shands Orthopaedics and Sports Medicine Institute in Gainesville, Florida."
Are there vacancies in this medical experiment for participants?
"Affirmative. Clinicaltrials.gov offers evidence that this clinical research, originally published on February 2nd 2022, is actively enrolling participants. 90 individuals must be recruited across 3 distinct sites for the trial to continue as planned."
What are the expected outcomes of this experiment?
"The primary measure of success for this study, assessed over a 24-month timeframe, is the Pain Interference score as determined by PROMIS. Secondary measures will observe patient performance in the 30-second Chair Stand Test (maximum repetitions within thirty seconds), 40m Fast Paced Walk Test (time to complete 4x10m walk) and Six Minute Walk Test (maximal distance covered)."
Share this study with friends
Copy Link
Messenger